1. The Direct and Indirect Costs Associated With Overactive Bladder Within a Commercially-Insured Population in the United States. Issue 9 (September 2018) Authors: Durden, Emily; Walker, David; Gray, Stephani; Fowler, Robert; Juneau, Paul; Gooch, Katherine Journal: Journal of occupational and environmental medicine Issue: Volume 60:Issue 9(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Predictors of Treatment with Duloxetine or Venlafaxine XR among Adult Patients Treated for Depression in Primary Care Practices in the United Kingdom. (7th June 2012) Authors: Shi, Nianwen; Durden, Emily; Torres, Amelito; Cao, Zhun; Happich, Michael Other Names: Nemeroff Charles B. Academic Editor. Journal: Depression research and treatment Issue: Volume 2012(2012) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. The economic burden of overactive bladder (OAB) and its effects on the costs associated with other chronic, age‐related comorbidities in the United States. Issue 5 (21st February 2018) Authors: Durden, Emily; Walker, David; Gray, Stephani; Fowler, Robert; Juneau, Paul; Gooch, Katherine Journal: Neurourology and urodynamics Issue: Volume 37:Issue 5(2018:Jun.) Page Start: 1641 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Predictors of glycemic control and diabetes-related costs among type 2 diabetes patients initiating therapy with liraglutide in the United States. (2nd April 2016) Authors: Durden, Emily; Lenhart, Greg; Lopez-Gonzalez, Lorena; Hammer, Mette; Langer, Jakob Journal: Journal of medical economics Issue: Volume 19:Number 4(2016) Page Start: 403 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗